In summary, targeting sirtuins, particularly SIRT1, SIRT2, SIRT6, and SIRT7, presents a multifaceted and promising approach for advancing therapeutic strategies against PCa. The gene discussed is SIRT7; the disease is posterior cortical atrophy.